Oncology Institute (TOIIW) Payables (2020 - 2026)

Oncology Institute (TOIIW) has 7 years of Payables data on file, last reported at $47.6 million in Q1 2026.

• For the quarter ending Q1 2026, Payables rose 62.68% year-over-year to $47.6 million; the trailing twelve-month figure through Mar 2026 stood at $47.6 million (up 62.68% YoY), and the FY2025 full-year result was $43.2 million, up 77.47% from the prior year.
• Payables for Q1 2026 stood at $47.6 million, up from $43.2 million in the prior quarter.
• Across five years, Payables topped out at $47.6 million in Q1 2026 and bottomed at $9.4 million in Q4 2022.
• The 5-year median for Payables is $15.8 million (2024), against an average of $22.1 million.
• Peak annual rise in Payables reached 50881.5% in 2022, while the deepest fall reached 39.76% in 2022.
• A 5-year view of Payables shows it stood at $9.4 million in 2022, then soared by 53.96% to $14.4 million in 2023, then jumped by 68.58% to $24.3 million in 2024, then soared by 77.47% to $43.2 million in 2025, then grew by 10.39% to $47.6 million in 2026.
• The last three Payables figures came in at $47.6 million (Q1 2026), $43.2 million (Q4 2025), and $35.6 million (Q3 2025), per Business Quant data.

Peer Comparison